Maria Pilar Domingo

7PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsGenetically modified treesMedical infection agents (incl. prions)Neural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2025
Combination of exhaled volatile organic compounds with serum biomarkers predicts respiratory infection severity.

Patricia Esteban, Santiago Letona-Gimenez, Maria Pilar Domingo

|Aug 29, 2024
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.

Andrea Sesma, Julian Pardo, Dolores Isla

|Mar 28, 2024
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.

Alba Moratiel-Pellitero, María Zapata-García, Marta Gascón-Ruiz

|Jan 21, 2023
A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.

Marta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra

|Apr 21, 2022
Integration of In Silico and In Vitro Analysis of Gliotoxin Production Reveals a Narrow Range of Producing Fungal Species.

Sergio Redrado, Patricia Esteban, María Pilar Domingo

|Jan 27, 2021
In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus.

Patricia Esteban, Sergio Redrado, Laura Comas

Pageof 2

Frequent Collaborators

7 joint publications

Eva M Gálvez

5 joint publications

Patricia Esteban

4 joint publications

Ariel Ramírez-Labrada

3 joint publications

Julián Pardo